Source: International Congress 2015 – Lung cancer therapy: clinical trials



Rating:

Share or cite this content

Citations should be made in the following way:
Angelica Tiotiu (Vandoeuvre-les-Nancy, France), Angelica Tiotiu, Isabelle Clerc-Urmès, Yves Martinet. Efficiency of erythropoiesis-stimulating agents (ESA) in the treatment of chemotherapy-induced anemia in patients with lung cancer (LC). Eur Respir J 2015; 46: Suppl. 59, 4842

Member's Comments

No comment yet.

Related content which might interest you: Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Pemetrexed in maintenance therapy of 164 patients with advanced non-small-cell lung cancer (NSCLC) Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Treatment of advanced non-small cell lung cancer with trofosfamide Source: Annual Congress 2013 –Advances in the therapy of lung cancer Year: 2013 Pulmonary function during lung cancer therapy: A retrospective analysis of patients treated with monotherapy or multimodal treatments Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Assesment of palliative care in lung cancer in Turkey (ASPECT study) Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Assessment of pain and nutritional status in patients suffering from lung cancer Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016 Gene therapy with DDMC-p53 with or without cisplatin and microwave ablation. A future concept for local treatment in lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Chemotherapy in elderly patients with non-small-cell lung cancer in Tunisian respiratory department Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 The rate of curative intended therapy against recurrent lung cancer before and after introduction of a CT-based follow-up program Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 Poor prognostic factors in advanced pulmonary adenocarcinoma patients receiving first-line gefitinib Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Influence of anxiety and depression on one-year survival in lung cancer patients Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016 Efficacy and safety of full oral vinorelbine (NVBO) on D1 and D8 with carboplatin (CBDCA) as first line treatment in advanced non-small lung cancer (NSCLC) patients: Results of a prospective study in nonrandomized population of 259 patients Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Muldisciplinary conference (MDC), oncological program (OP) and practice guidelines (GL): The experience of the lung cancer (LC) clinic of a cancer hospital Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Prognostic factors for stage IV lung adenocarcinoma patients receiving retreatment with EGFR-TKI Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Site of first progression (PR) differs between stage III NSCLC patients treated with simultaneous radiochemotherapy (RTCT) and those treated with radiotherapy (RT) alone following induction chemotherapy (CT) Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Erlotinib (E) in elderly pts with NSCL: Experience at a tertiary referral center Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Survival in lung cancer: Associated factors in Tunisian patients Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Bevacizumab (Bv) in elderly pts with NSCLC: Experience at a tertiary referral center Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013